Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDLZ vs GSK✓SelectedUSD · GSKMDLZ vs GSK performance historyLatest closeAs of-1.32%11/19
Stock and ETF performance explorer

MDLZ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+94.5%
GSK return
+97.7%
Excess return
-3.1%
Maximum drawdown
-29.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.3%-1.6%+0.2%-0.8%
7D-1.3%-4.7%+3.4%+0.3%
30D+2.7%-4.7%+7.4%+4.3%
3M+3.3%-8.8%+12.0%+6.3%
6M+9.0%-4.6%+13.7%+10.4%
YTD+25.2%+1.0%+24.2%+23.4%
1Y+21.3%+6.9%+14.4%+17.1%
3Y+1.7%+52.5%-50.8%-16.4%
5Y+24.3%+40.3%-16.0%+3.9%
All+94.5%+97.7%-3.1%+37.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling